Cost of Drug-Related Monitoring Requirements for Glatiramer Acetate and Other Multiple Sclerosis Disease-Modifying Therapies (Dmts). van Engen A, Wu Y, Tchoukouaha T, Aran Terol P, Gandhi S Value Health. 2015 Nov; 18(7):A753. Epub 2015 Oct 20. PMID: 26534221. Abstract CommentRecommendBookmarkWatch